Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine M72/AS01E in Participants With Well-controlled HIV
Condition: Human Immunodeficiency Virus Interventions: Biological: M72/AS01E Mycobacterium tuberculosis vaccine; Biological: Placebo Sponsor: Bill & Melinda Gates Medical Research Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials